BioXcel Therapeutics (BTAI) Change in Inventory (2022 - 2026)
BioXcel Therapeutics (BTAI) posted Change in Inventory of -$17000.0 for Q2 2026, up 92.34% on a QoQ basis from -$222000.0 in Q1 2026, and up 87.5% year-over-year from -$9066.7 in Q2 2025.
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Change in Inventory (2022 - 2026) Analysis & Trends
BioXcel Therapeutics has reported Change in Inventory for 5 years, with the latest figure at -$17000.0 in Q2 2026.
- On a quarterly basis, Change in Inventory rose 87.5% year-over-year to -$17000.0 in Q2 2026; TTM through Jun 2026 was -$23000.0, a 98.94% increase from a year earlier, with the FY2025 full-year figure at $43000.0, up 103.28% from the prior year.
- Change in Inventory was -$17000.0 for Q2 2026 at BioXcel Therapeutics, up from -$222000.0 in the prior quarter.
- The five-year high for Change in Inventory was $713000.0 in Q2 2022, with the low at -$1.2 million in Q3 2024.
- Average Change in Inventory over 5 years is $26833.3, with a median of -$22000.0 recorded in 2023.
- The largest YoY upside for Change in Inventory was 1457.58% in 2024 against a maximum downside of 3033.33% in 2024.
- Over 5 years, Change in Inventory stood at $577000.0 in 2022, then plunged by 104.68% to -$27000.0 in 2023, then tumbled by 3033.33% to -$846000.0 in 2024, then jumped by 131.09% to $263000.0 in 2025, then sank by 106.46% to -$17000.0 in 2026.
- The last three Change in Inventory figures came in at -$17000.0 (Q2 2026), -$222000.0 (Q1 2026), and $263000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | - |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 | -17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,000.00 |
| Mar 31, 2026 | -222,000.00 |
| Dec 31, 2025 | 263,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Jun 30, 2025 | -136,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | -846,000.00 |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 448,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | 93,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | 577,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 713,000.00 |
| Mar 31, 2022 | 682,000.00 |